Oxford Asset Management’s Inozyme Pharma INZY Stock Holding History

Oxford Asset Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-361,557	Closed	-$1.45M	–	593
2025 Q2	$1.45M	Buy	+361,557	New	+$895K	0.47%	34

Oxford Asset Management's INZY Position: Q3 2025 in Review

Oxford Asset Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 361,557 shares — an estimated $1.45M sold.

Oxford Asset Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $1.45M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Oxford Asset Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Oxford Asset Management sold 361,557 Inozyme Pharma shares in Q3 2025, an estimated $1.45M.
Oxford Asset Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Oxford Asset Management's Inozyme Pharma position peaked at $1.45M in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.